Press Releases

Snke Spins Off from Brainlab: To Accelerate Growth and Open New Market Opportunities

brainlab-stefan-vilsmeier-chief-executive-officer.jpg

Strategic separation allows both companies to focus and scale independently while maintaining close collaboration

Munich, June 22, 2025

Snke Holding SE (“Snke”), a pioneering healthtech company, today announced its official spin-off from the Brainlab Group. The strategic move enables both Brainlab and Snke to sharpen their focus, attract targeted investment to scale, and pursue distinct growth paths.

Snke is an early-stage venture incubated by Brainlab and was originally founded to tackle complex, industry-wide challenges in medtech with scalable and impactful technologies. The company’s mission is to provide a framework that simplifies the connection of stakeholders, products, and services across healthcare—accelerating the adoption of innovation through a trusted orchestration layer that enables its consumers to build resource-efficient, effective and value-based solutions.

“Thanks to the substantial investment that already went into Snke, many of the puzzle pieces are coming together,” said Stefan Vilsmeier, CEO of Snke and Chairman of the Supervisory Board at Brainlab. “Now, Snke can dedicate our full focus to complete the picture and bring some first products to market. While Brainlab remains a strategic partner, independence allows Snke to attract new collaborators—each contributing their piece. As a neutral orchestrator, Snke can help shape the next-generation standards that will benefit the entire industry, including Brainlab.”

Although Snke is now structurally independent, the companies will maintain a close working relationship. During its initial growth phase, Snke will receive transitional services from Brainlab. In turn, Brainlab will act as a customer and strategic distributor for selected Snke technologies that complement its existing workflows. To maintain long-term strategic alignment, Brainlab will retain a 6.84% stake in Snke.

The company’s future product portfolio will span multiple layers of technical abstraction—from low-level APIs to end-user applications—and includes technologies at different stages of market maturity. While some components are still in early-stage development, others, like structured radiological reporting solutions from Mint Medical, are already widely adopted in clinical routine, research and registries. Together, these elements form the foundation of a modular, interoperable operating system for data-driven healthcare, including:

  • Edge devices for digital operating rooms

  • AI-enhanced anatomical modeling and simulation

  • Structured radiological reporting

  • Mixed reality surgical applications

  • Gamified curriculum solutions

  • Interoperable hybrid infrastructure for hospital IT

  • Privacy-compliant data governance frameworks

Additionally, Snke acts as a facilitator, connecting healthcare providers with solution developers, including Brainlab, who rely on access to structured, privacy-compliant data for innovation.

By focusing on B2B components and foundational infrastructure, Snke enables broader industry adoption and introduces new business models to the sector that require scale to be viable.

Press contact:

Snke

Headquartered in Munich, Snke is transforming healthtech with scalable, data-driven innovation powered by AI and big data. We’re more than 350 experts specializing in healthcare IT, advanced visualization and simulation, data science and machine learning. By delivering a trusted orchestration layer, Snke empowers healthcare providers, clinical societies, patients and other healthtech companies to utilize cutting-edge solutions for improving treatments and enhancing patient outcomes. Beyond our Munich headquarters, we have core teams in Chicago, Heidelberg and Tel Aviv. Snke fosters global collaboration to create technologies that are smart, enabling and holistic—helping healthtech to scale up data innovation.

For more information, visit Snke or follow us on LinkedIn, Facebook and Instagram.